0001999371-24-006618.txt : 20240524
0001999371-24-006618.hdr.sgml : 20240524
20240524170504
ACCESSION NUMBER: 0001999371-24-006618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bell Margaret Smith
CENTRAL INDEX KEY: 0001716713
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 24985393
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP.
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
BUSINESS PHONE: 212-980-9155
MAIL ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
bell-form4.xml
X0508
4
2024-05-23
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001716713
Bell Margaret Smith
C/O TONIX PHARMACEUTICALS HOLDING CORP.
26 MAIN STREET, SUITE 101
CHATHAM
NJ
07928
1
0
0
0
0
Stock Option
0.1745
2024-05-23
4
A
0
104621
0.00
A
2025-05-23
2034-05-23
Common Stock
104621
104621
D
The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders.
/s/ Jessica Morris, Attorney-in-Fact
2024-05-24